After a national search, Corey Speers, M.D., Ph.D., has been named chair of the UAB Department of Radiation Oncology, effective May 12, 2025.

The regulator HIF1α functions in a cancer-microenvironment that lacks oxygen, and it may be involved in resistance to immune checkpoint blockade therapy.

The AI in Medicine and Nursing Symposium, hosted by the UAB Heersink School of Medicine, UAB Medicine, UAB School of Health Professions, UAB School of Nursing, and Maastricht University Faculty of Science and Engineering, concluded successfully, bringing together leading experts, researchers,...

Andrew McDonald, M.D., M.S.Andrew McDonald, M.D., M.S., was appointed the second holder of the Radiation Oncology Accelerated (ROAR) Southeast Cancer Foundation Endowed Chair in Radiation Oncology by the Board of Trustees of the University of Alabama System during the Sept. 5 board meeting.

Lewis Z. Shi, M.D., Ph.D.University of Alabama at Birmingham (UAB) Department of Radiation Oncology researchers have identified HIF1α-regulated glycolysis as a key metabolic control of IFN-γ production in hypoxic T cells and immune checkpoint blocker (ICB) response.

Twenty-two UAB employees recently graduated from the Emerging Leaders Series (ELS) fall 2024 leadership development program. The program, presented by UAB Medicine’s Leadership Development Office (LDO), recognized its second cohort of graduates at a ceremony on Nov.

UAB Department of Radiation Oncology providers are among this year’s top-performing physicians and advanced practice providers (APPs) honored for excellence in patient experience. The Office of Patient Experience and Engagement (OPXE) recognized 446 providers for the exceptional care they delivered to patients in fiscal year 2024.

The UAB Department of Radiation Oncology is pleased to announce the promotion of three faculty members in the areas of medical physics, radiation oncology, and radiobiology, effective Oct. 1, 2024.

Taylor Schanel, GS4Taylor Schanel (GS4) has been appointed as a predoctoral trainee on a National Institute of Neurological Disorders and Stroke (NINDS) Training Program in Brain Tumor Biology T32 grant for her investigation into underlying mechanisms of Tumor Treating Fields (TTFields) efficacy in brain cancer.

Gobind Gill, M.D.Gobind Gill, M.D., joined the UAB Department of Radiation Oncology as assistant professor on Sept. 3, 2024.

By Mackenzie Sexton New technology presents new opportunities in patient care, something that Yogesh Kumar, Ph.D., knew well when he began researching the use of machine-learning software in cancer treatment. When he received this year’s Mary Ann Harvard NextGen Scholar Award for his work integrating artificial intelligence into radiotherapy, he knew he was on the right track.

The UAB Department of Radiation Oncology welcomed four new residents, including three radiation oncology trainees and one medical physics trainee, on July 1, 2024. Samuel Chen, M.D.; Reza Djavadian, M.D., Ph.D.; and Kayla Steed, M.D., Ph.D.

  J. David Roveda Jr., M.D., joins the UAB Department of Radiation as the first UAB-employed radiation oncologist at the Infirmary Cancer Center in Mobile, Alabama, under the new affiliation between UAB Health System and Infirmary Health announced in January.

Udbhav Ram, an international scholar from McMaster University, recently joined Carlos E. Cardenas, Ph.D., in his lab to study and research and serve as an undergraduate ambassador.

The UAB Department of Radiation Oncology honored its 2024 graduating radiation oncology and medical physics residents at a dinner celebration and awards ceremony June 14 in Homewood, Alabama.

Seven chief residents at UAB recently graduated from the Chief Residents Leadership Series Spring 2024 program. The program, presented by UAB Medicine’s Leadership Development Office, recognized its graduates at a ceremony on May 30, 2024.

The UAB Hazelrig-Salter Radiation Oncology Center and the Kirklin Clinic at Acton Road will obtain their ASTRO-APEx accreditation until September 2027.

The Marnix E. Heersink Institute for Biomedical Innovation held a symposium titled "Generative AI for Healthcare: Progress or Peril" with multiple speakers, all innovators in the field of health care, on Tuesday, Sept.

In the last several years, UAB Medicine and Heersink School of Medicine have worked to bring leadership development to faculty and staff through the UAB Medicine Institute for Leadership and Momentum in Medicine programs.

Anupam Agarwal, M.D., dean of the Heersink School of Medicine, welcomed faculty members and their families to the Endowed Chairs and Professorships Reception on April 25.

Even when at odds with his health, Matalon continued his academic excellence and service to the field of lung disease research.

The potential affiliation will help RMC Health System to sustain and improve access to high-quality, low-cost care close to home.

UAB Medicine Institute for Leadership has named their next cohort for Spring 2023: cohort six.

The Heersink School of Medicine communications staff sat down with Dr. Lewis Zhichang Shi to gain insights about the research of this study, UAB, and the science community.

The clinically approved drug ruxolitinib suppressed a mouse model of melanoma that is resistant to immune checkpoint blockers.

Because the beam of photons is so tightly focused, proton therapy has little effect on surrounding healthy tissue, making it especially beneficial for young patients.

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.

UAB and Proton International open the first proton therapy center for cancer treatment in Alabama.

This new, non-invasive way to deliver radiation has helped one Alabama man complete optometry school and launch his new career.